{"id":{"repo_id":"lethbridge","oai_identifier":"oai:opus.uleth.ca:10133/5697"},"canonical_url":"https://search.ndltd.org/etd/lethbridge/oai:opus.uleth.ca:10133/5697","repository":{"repo_id":"lethbridge","name":"University of Lethbridge","base_url":"https://opus.uleth.ca/server/oai/request"},"display":{"title":"Cannabinol inhibits proliferation and induces cell cycle arrest and apoptosis in glioblastoma, hepatocellular carcinoma and breast cancer cells","abstract":"Cannabis sativa is an agriculturally and medicinally important plant with many pharmaceutical properties. Cancer is a deadly disease; it is estimated that it will cause over 80 thousand deaths in 2019 in Canada. Although numerous studies have demonstrated that cannabinoids have anti-tumorous properties in various cancers, the anti-malignant activities of cannabinol (CBN) on carcinogenesis and underlying mechanisms remain largely unknown. In this study, we provide evidence that CBN inhibits proliferation of A172, HB8065 and HCC1806 cells in a dose- and time-dependent manner. CBN regulates expression of cannabinoid receptors, CB2, GPR55 and GPR18 in different cell lines, while reducing levels of phosphorylated ERK1/2 in HCC1806 and phosphorylated AKT in A172 and HB8065 cells. We find that CBN induces apoptosis through downregulation of p21 and p27 and a G1 or S-phase cell cycle arrest through a dose-dependent downregulation of cyclin E1, CDK1 and CDK2. These data support the medicinal potential of CBN in anti-cancer therapy.","abstract_html":"Cannabis sativa is an agriculturally and medicinally important plant with many pharmaceutical properties. Cancer is a deadly disease; it is estimated that it will cause over 80 thousand deaths in 2019 in Canada. Although numerous studies have demonstrated that cannabinoids have anti-tumorous properties in various cancers, the anti-malignant activities of cannabinol (CBN) on carcinogenesis and underlying mechanisms remain largely unknown. In this study, we provide evidence that CBN inhibits proliferation of A172, HB8065 and HCC1806 cells in a dose- and time-dependent manner. CBN regulates expression of cannabinoid receptors, CB2, GPR55 and GPR18 in different cell lines, while reducing levels of phosphorylated ERK1/2 in HCC1806 and phosphorylated AKT in A172 and HB8065 cells. We find that CBN induces apoptosis through downregulation of p21 and p27 and a G1 or S-phase cell cycle arrest through a dose-dependent downregulation of cyclin E1, CDK1 and CDK2. These data support the medicinal potential of CBN in anti-cancer therapy.","abstract_has_math":false,"creators":["Zhong, Nuanying","University of Lethbridge. Faculty of Arts and Science"],"institution":"Lethbridge, Alta. : University of Lethbridge, Dept. of Biological Sciences","degree_name":null,"degree_level":"Masters","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Kovalchuk, Igor"],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020","date_published":"2020","updated_at":"2026-11-19T05:21:30Z","subjects":["Cancer cells","Cannabinoids","Cannabis — Therapeutic use","Carcinogenesis","Marijuana — Therapeutic use","Medical Marijuana — therapeutic use"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/10133/5697","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/10133/5697","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://opus.uleth.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopus.uleth.ca%3A10133%2F5697","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.supervisor","label":"Supervisor","values":["Kovalchuk, Igor"]},{"key":"dc:creator","label":"Author","values":["Zhong, Nuanying","University of Lethbridge. Faculty of Arts and Science"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2020-03-20T16:54:42Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2020-03-20T16:54:42Z"]},{"key":"dc:date.issued","label":"Date","values":["2020"]},{"key":"dc:publisher","label":"Institution","values":["Lethbridge, Alta. : University of Lethbridge, Dept. of Biological Sciences"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Department of Biological Sciences"]},{"key":"dc:publisher.faculty","label":"Dc Publisher Faculty","values":["Arts and Science"]},{"key":"dc:relation.ispartofseries","label":"Dc Relation Ispartofseries","values":["Thesis (University of Lethbridge. Faculty of Arts and Science)"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Masters"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Cancer cells","Cannabinoids","Cannabis — Therapeutic use","Carcinogenesis","Marijuana — Therapeutic use","Medical Marijuana — therapeutic use"]},{"key":"dc:subject.proquest","label":"Dc Subject Proquest","values":["Cellular biology [0379]","Oncology [0992]","Molecular biology [0307]"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]},{"key":"dc:rights.proquest","label":"Dc Rights Proquest","values":["Yes"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/10133/5697"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Cannabis sativa is an agriculturally and medicinally important plant with many pharmaceutical properties. Cancer is a deadly disease; it is estimated that it will cause over 80 thousand deaths in 2019 in Canada. Although numerous studies have demonstrated that cannabinoids have anti-tumorous properties in various cancers, the anti-malignant activities of cannabinol (CBN) on carcinogenesis and underlying mechanisms remain largely unknown. In this study, we provide evidence that CBN inhibits proliferation of A172, HB8065 and HCC1806 cells in a dose- and time-dependent manner. CBN regulates expression of cannabinoid receptors, CB2, GPR55 and GPR18 in different cell lines, while reducing levels of phosphorylated ERK1/2 in HCC1806 and phosphorylated AKT in A172 and HB8065 cells. We find that CBN induces apoptosis through downregulation of p21 and p27 and a G1 or S-phase cell cycle arrest through a dose-dependent downregulation of cyclin E1, CDK1 and CDK2. These data support the medicinal potential of CBN in anti-cancer therapy."]},{"key":"dc:description.sponsorship","label":"Dc Description Sponsorship","values":["Mitacs"]},{"key":"dc:title","label":"Title","values":["Cannabinol inhibits proliferation and induces cell cycle arrest and apoptosis in glioblastoma, hepatocellular carcinoma and breast cancer cells"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.supervisor":["Kovalchuk, Igor"],"dc:creator":["Zhong, Nuanying","University of Lethbridge. Faculty of Arts and Science"],"dc:date.accessioned":["2020-03-20T16:54:42Z"],"dc:date.available":["2020-03-20T16:54:42Z"],"dc:date.issued":["2020"],"dc:description.abstract":["Cannabis sativa is an agriculturally and medicinally important plant with many pharmaceutical properties. Cancer is a deadly disease; it is estimated that it will cause over 80 thousand deaths in 2019 in Canada. Although numerous studies have demonstrated that cannabinoids have anti-tumorous properties in various cancers, the anti-malignant activities of cannabinol (CBN) on carcinogenesis and underlying mechanisms remain largely unknown. In this study, we provide evidence that CBN inhibits proliferation of A172, HB8065 and HCC1806 cells in a dose- and time-dependent manner. CBN regulates expression of cannabinoid receptors, CB2, GPR55 and GPR18 in different cell lines, while reducing levels of phosphorylated ERK1/2 in HCC1806 and phosphorylated AKT in A172 and HB8065 cells. We find that CBN induces apoptosis through downregulation of p21 and p27 and a G1 or S-phase cell cycle arrest through a dose-dependent downregulation of cyclin E1, CDK1 and CDK2. These data support the medicinal potential of CBN in anti-cancer therapy."],"dc:description.sponsorship":["Mitacs"],"dc:identifier.uri":["https://hdl.handle.net/10133/5697"],"dc:language.iso":["en_US"],"dc:publisher":["Lethbridge, Alta. : University of Lethbridge, Dept. of Biological Sciences"],"dc:publisher.department":["Department of Biological Sciences"],"dc:publisher.faculty":["Arts and Science"],"dc:relation.ispartofseries":["Thesis (University of Lethbridge. Faculty of Arts and Science)"],"dc:rights.proquest":["Yes"],"dc:subject":["Cancer cells","Cannabinoids","Cannabis — Therapeutic use","Carcinogenesis","Marijuana — Therapeutic use","Medical Marijuana — therapeutic use"],"dc:subject.proquest":["Cellular biology [0379]","Oncology [0992]","Molecular biology [0307]"],"dc:title":["Cannabinol inhibits proliferation and induces cell cycle arrest and apoptosis in glioblastoma, hepatocellular carcinoma and breast cancer cells"],"dc:type":["Thesis"],"others:access_status":["open.access"],"thesis:degree_level":["Masters"]},"updated_at":"2026-11-19T05:21:30Z"}